VANCOUVER, BC / ACCESS Newswire / January 24, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, provides ...

CEO and biomedical engineer George K. Lewis will discuss the clinical effectiveness of sustained acoustic medicine in ...

Preliminary ResultsPentixapharm Holding AG Closes the 2024 Financial Year With a Loss of EUR 14 Million, Including Risk Provisions for Myelo Amounting to EUR 7 Million24-Jan-2025 / 17:00 ...

VANCOUVER, BC / ACCESS Newswire / January 24, 2025 / At the request of the Canadian Investment Regulatory Organization, Onco-Innovations Limited (the "Company") wishes to confirm that the Company's ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS ...

Sales ResultSignificant progress in all operating areas; stable fourth quarter leads to annual sales of EUR 12.2 million (+6%) 24.01.2025 / 07:00 CET/CESTThe issuer is solely responsible for the ...

CLASS data FOR NOVEL APPROACH TO CANCER treatmentParsortix system used to identify patients with highly metastatic CTC clusters for targeted treatmentNew treatment strategy provides 'uncharted ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

In many countries, the social welfare sector is struggling with enormous cost-cutting pressures, labour shortage and the growing demand for its services. VTT Technical Research Centre of Finland, ...

Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery Award winners by category DELIVERY AND DEVICE INNOVATIONSHL Medical for Elexy™ reusable electromechanical ...

Are you looking for a pharma job in the UK? In this article, we’ve put together a list of the best pharma organisations to ...

SAN DIEGO, CA / ACCESS Newswire / January 23, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment ...